; and (C) between January 2019 and January 2020, among 36 States and the District of Columbia, suspected stimulant overdoses, including methamphetamine, treated in emergency departments increased by 23 percent. (8) Methamphetamine-related overdose deaths will likely continue to increase in 2020, due in part to the ongoing COVID–19 pandemic, which makes obtaining treatment for substance use disorders, including methamphetamine use, more difficult. (9) The increase in methamphetamine use and the negative respiratory and pulmonary health effects associated with its use has caused the National Institute on Drug Abuse to warn clinicians to be prepared to monitor adverse effects when treating individuals using methamphetamine who also have COVID–19. (10) Since the onset of COVID–19 in the United States, the number of law enforcement and first responder agencies entering data into nationwide overdose mapping applications to track real-time suspected overdoses, including methamphetamine overdoses, has increased. (11) In the first 9 months of fiscal year 2020, there was a 52-percent increase in the amount of methamphetamine seized by U.S. Customs and Border Protection. (12) Public reports indicated that Mexican cartels may be stockpiling money and illicit drugs, including methamphetamine, on both sides of the Southwest Border and that the Drug Enforcement Administration is preparing to respond to any potential surge in supply. (13) Intentional preparation to counter any surges in production, distribution, and use are essential in lowering methamphetamine-related overdose deaths and substance use disorders. 3. Declaration of emerging threat (a) In general Congress declares methamphetamine an emerging drug threat, as defined in section 702 of the Office of National Drug Control Policy Reauthorization Act of 1998 ( 21 U.S.C. 1701 ), in the United States. (b) Required emerging threat response plan Not later than 90 days after the date of enactment of this Act, the Director of the Office of National Drug Control Policy shall